Tang Rong, Saksena Mansi, Coopey Suzanne B, Fernandez Leopoldo, Buckley Julliette M, Lei Lan, Aftreth Owen, Koerner Frederick, Michaelson James, Rafferty Elizabeth, Brachtel Elena, Smith Barbara L
1 Division of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA.
2 Division of Breast Surgery, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya Medical School of Central South University, Changsha, China.
Br J Radiol. 2016;89(1058):20150581. doi: 10.1259/bjr.20150581. Epub 2015 Nov 16.
Micro-CT is a promising modality to determine breast tumour size in three dimensions in intact lumpectomy specimens. We compared the accuracy of tumour size measurements using specimen micro-CT with measurements using multimodality pre-operative imaging.
A tabletop micro-CT was used to image breast lumpectomy specimens. The largest tumour dimension on three-dimensional reconstructed micro-CT images of the specimen was compared with the measurements determined by pre-operative mammography, ultrasound and MRI. The largest dimension of pathologic invasive cancer size was used as the gold standard reference to assess the accuracy of imaging assessments.
50 invasive breast cancer specimens in 50 patients had micro-CT imaging. 42 were invasive ductal carcinoma, 6 were invasive lobular carcinoma and 2 were other invasive cancer. Median patient age was 63 years (range 33-82 years). When compared with the largest pathologic tumour dimension, micro-CT measurements had the best correlation coefficient (r = 0.82, p < 0.001) followed by MRI (r = 0.78, p < 0.001), ultrasound (r = 0.61, p < 0.001) and mammography (r = 0.40, p < 0.01). When compared with pre-operative modalities, micro-CT had the best correlation coefficient (r = 0.86, p < 0.001) with MRI, followed by ultrasound (r = 0.60, p < 0.001) and mammography (r = 0.54, p < 0.001). Overall, mammography and ultrasound tended to underestimate the largest tumour dimension, while MRI and micro-CT overestimated the largest tumour dimension more frequently.
Micro-CT is a potentially useful tool for accurate assessment of tumour dimensions within a lumpectomy specimen. Future studies need to be carried out to see if this technology could have a role in margin assessment.
Micro-CT is a promising new technique which could potentially be used for rapid assessment of breast cancer dimensions in an intact lumpectomy specimen in order to guide surgical excision.
显微计算机断层扫描(Micro-CT)是一种很有前景的技术,可用于完整保乳手术标本中三维测定乳腺肿瘤大小。我们比较了使用标本显微计算机断层扫描测量肿瘤大小与使用多模态术前成像测量的准确性。
使用台式显微计算机断层扫描对乳腺保乳手术标本进行成像。将标本三维重建显微计算机断层扫描图像上肿瘤的最大尺寸与术前乳腺X线摄影、超声和磁共振成像测定的尺寸进行比较。将病理浸润癌大小的最大尺寸用作金标准参考,以评估成像评估的准确性。
50例患者的50个浸润性乳腺癌标本进行了显微计算机断层扫描成像。42例为浸润性导管癌,6例为浸润性小叶癌,2例为其他浸润性癌。患者中位年龄为63岁(范围33 - 82岁)。与最大病理肿瘤尺寸相比,显微计算机断层扫描测量的相关系数最佳(r = 0.82,p < 0.001),其次是磁共振成像(r = 0.78,p < 0.001)、超声(r = 0.61,p < 0.001)和乳腺X线摄影(r = 0.40,p < 0.01)。与术前检查方法相比,显微计算机断层扫描与磁共振成像的相关系数最佳(r = 0.86,p < 0.001),其次是超声(r = 0.60,p < 0.001)和乳腺X线摄影(r = 0.54,p < 0.001)。总体而言,乳腺X线摄影和超声往往低估肿瘤的最大尺寸,而磁共振成像和显微计算机断层扫描更频繁地高估肿瘤的最大尺寸。
显微计算机断层扫描是准确评估保乳手术标本内肿瘤尺寸的潜在有用工具。未来需要开展研究,以确定该技术是否可用于切缘评估。
显微计算机断层扫描是一项有前景的新技术,可潜在地用于快速评估完整保乳手术标本中的乳腺癌尺寸,以指导手术切除。